Merional s.c. | Merional i.m. | P value | |
---|---|---|---|
N. of patients starting MOS | 83 | 80 | |
Duration of MOS (days)* | 13.8 ± 1.7 | 14.6 ± 2.1 | 0.02 |
hMG total dose (IU)* | 2168.6 ± 729.55 | 2595.1 ± 951.2 | 0.002 |
AUC0-t of E2 (log-transformed pmol/L*days)* | 8.7 ± 0.6 | 8.8 ± 0.5 | NS |
CMAX of E2 (pmol/L) * | 2215.5 ± 1288.4 | 2416.2 ± 1258.5 | NS |
Completed COS cycles (OPUs) | 77 | 73 | |
N. of oocytes retrieved/OPU* | 8.0 ± 3.8 | 8.6 ± 3.7 | NS |
N. of fertilized oocytes/OPU* | 3.6 ± 2.7 | 4.0 ± 3.0 | NS |
N. of embryo transfers (ETs) | 77 | 73 | |
hCG positive tests | 32 | 25 | |
Pregnancy rate/started cycle (%) a | 38.5 | 31.2 | NS |
Pregnancy rate/ET (%)a | 41.5 | 34.2 | NS |
Clinical pregnancies | 21 | 19 | |
Clinical pregnancy rate/started cycle (%) b | 25.3 | 23.7 | NS |
Clinical pregnancy rate/ET (%)b | 27.3 | 26.0 | NS |